Toshiba Corp removed two board directors Junji Ota, chairman of Toshiba's audit committee, and its member Takashi Yamauchi in its list of candidates pending shareholder approval in June after revelations of the conglomerate's inappropriate handling of foreign activist investors.
The exclusion of the two brings the total number of nominees to 11 from 13.
Independent lawyers concluded earlier this month Toshiba had colluded with the Ministry of Economy to fend off activist foreign investors in the company's general shareholders' meeting last summer by applying pressure.
The foreign investors requested the investigation.
Major Toshiba shareholders include Singapore-based firms Effissimo Capital Management Pte Ltd and 3D Investment Partners Pte Ltd, which has demanded that Toshiba's board chairman Osamu Nagayama and three other executives resign.
Toshiba has been accepting foreign investments in recent years to cope with its financial struggles.
In unanimously deciding on the removal, Toshiba said it took the independent panel's report "seriously." It added that it would strive to objectively and transparently, with the participation of third parties, identify the root cause without delay.
Two senior executives mentioned in the independent panel's report, Corporate Senior Executive Vice President Masayasu Toyohara and Corporate Senior Vice President Masaharu Kamo, are set to retire on June 25, when the shareholders meet.


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Instagram Outage Disrupts Thousands of U.S. Users
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



